Healthcare Realty Trust (NYSE:HR – Free Report) had its target price trimmed by Wells Fargo & Company from $20.00 to $18.00 in a report issued on Monday morning,Benzinga reports. The brokerage currently has an equal weight rating on the real estate investment trust’s stock.
A number of other research analysts also recently issued reports on the company. JPMorgan Chase & Co. lifted their price target on Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Royal Bank Of Canada boosted their price target on Healthcare Realty Trust from $21.00 to $22.00 and gave the stock a “sector perform” rating in a research report on Friday, August 7th. Cantor Fitzgerald upped their price objective on Healthcare Realty Trust from $22.00 to $24.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. UBS Group decreased their price objective on Healthcare Realty Trust from $21.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, October 13th. Finally, Weiss Ratings raised Healthcare Realty Trust from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 30th. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $21.36.
Healthcare Realty Trust Stock Performance
NYSE HR opened at $17.21 on Monday. The company has a market cap of $5.90 billion, a PE ratio of -66.21 and a beta of 0.97. The firm’s 50 day moving average price is $18.35 and its 200-day moving average price is $19.36. Healthcare Realty Trust has a 52-week low of $16.31 and a 52-week high of $22.04.
Healthcare Realty Trust (NYSE:HR – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The real estate investment trust reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.53). The business had revenue of $278.58 million during the quarter, compared to the consensus estimate of $271.60 million. Healthcare Realty Trust had a negative return on equity of 1.91% and a negative net margin of 7.59%. The business’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period last year, the firm earned $0.41 EPS. Healthcare Realty Trust has set its FY 2026 guidance at 1.620-1.660 EPS. On average, analysts forecast that Healthcare Realty Trust will post 1.65 earnings per share for the current fiscal year.
Healthcare Realty Trust Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 11th were paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 5.6%. The ex-dividend date was Tuesday, August 11th. Healthcare Realty Trust’s payout ratio is -369.23%.
Insider Buying and Selling
In related news, COO Robert Hull sold 21,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $19.11, for a total transaction of $401,310.00. Following the completion of the sale, the chief operating officer owned 276,338 shares of the company’s stock, valued at $5,280,819.18. This represents a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.56% of the stock is owned by insiders.
Institutional Investors Weigh In On Healthcare Realty Trust
Several institutional investors have recently bought and sold shares of HR. Continuum Advisory LLC acquired a new position in shares of Healthcare Realty Trust during the second quarter worth $26,000. TD Waterhouse Canada Inc. purchased a new stake in shares of Healthcare Realty Trust during the 3rd quarter valued at $28,000. IFP Advisors Inc lifted its holdings in shares of Healthcare Realty Trust by 310.4% during the 2nd quarter. IFP Advisors Inc now owns 1,773 shares of the real estate investment trust’s stock valued at $36,000 after purchasing an additional 1,341 shares during the last quarter. Versant Capital Management Inc boosted its position in shares of Healthcare Realty Trust by 48.2% in the 2nd quarter. Versant Capital Management Inc now owns 2,274 shares of the real estate investment trust’s stock worth $46,000 after purchasing an additional 740 shares in the last quarter. Finally, Main Street Group LTD acquired a new stake in shares of Healthcare Realty Trust in the 1st quarter worth $42,000.
Healthcare Realty Trust Company Profile
Healthcare Realty Trust Incorporated (NYSE: HR) is a real estate investment trust focused on owning, managing, acquiring and developing outpatient healthcare properties. Its portfolio primarily includes medical office buildings, ambulatory surgery centers, outpatient facilities and other properties used by healthcare providers.
The company leases space to health systems, physician groups and other healthcare organizations, with properties generally located on or near hospital campuses and in growing outpatient care settings.
Recommended Stories
- Five stocks we like better than Healthcare Realty Trust
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
